Literature DB >> 6706074

Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies.

S Poucell, J Ireton, P Valencia-Mayoral, E Downar, L Larratt, J Patterson, L Blendis, M J Phillips.   

Abstract

The hepatic morphological findings in 3 patients treated with amiodarone, a potent and effective antiarrhythmic drug, are reported. An enlarged liver and mild elevation of hepatic enzymes were the most important clinical findings. Fibrosis, cholangitis, mixed inflammatory infiltrate, and cytoplasmic granularity of the hepatocytes were the main histologic changes common to all cases. In 2 of the cases the presence of Mallory bodies was confirmed by electron microscopy. In 1 of these 2 cases, Mallory bodies were also confirmed by immunostaining. Ultrastructurally, numerous cytoplasmic inclusions with a membranous or lamellar structure identical to those described in phospholipidosis were the most striking features seen in hepatocytes, biliary epithelial cells, Kupffer cells, and endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6706074

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

1.  Amiodarone--an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine.

Authors:  N A Shaikh; E Downar; J Butany
Journal:  Mol Cell Biochem       Date:  1987-08       Impact factor: 3.396

2.  Glucosylceramide and lysophosphatidylcholines as potential blood biomarkers for drug-induced hepatic phospholipidosis.

Authors:  Kosuke Saito; Keiko Maekawa; Masaki Ishikawa; Yuya Senoo; Masayo Urata; Mayumi Murayama; Noriyuki Nakatsu; Hiroshi Yamada; Yoshiro Saito
Journal:  Toxicol Sci       Date:  2014-06-30       Impact factor: 4.849

3.  Granular cells as a marker of early amiodarone hepatotoxicity: a pathological and analytical study.

Authors:  N A Shepherd; A M Dawson; P R Crocker; D A Levison
Journal:  J Clin Pathol       Date:  1987-04       Impact factor: 3.411

4.  Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case report.

Authors:  Hiroki Oikawa; Chihaya Maesawa; Ryo Sato; Kanta Oikawa; Hiroyuki Yamada; Seizo Oriso; Sadahide Ono; Akiko Yashima-Abo; Koji Kotani; Kazuyuki Suzuki; Tomoyuki Masuda
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

Review 5.  Drug-induced "allergic hepatitis".

Authors:  P Podevin; M Biour
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 6.  Adverse effects of amiodarone. Pathogenesis, incidence and management.

Authors:  G V Naccarelli; R L Rinkenberger; A H Dougherty; D M Fitzgerald
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

7.  Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis.

Authors:  A Nonomura; Y Mizukami; M Unoura; K Kobayashi; Y Takeda; R Takeda
Journal:  Gastroenterol Jpn       Date:  1992-08

8.  Role of vitamin-E on rat liver-amiodarone: an ultrastructural study.

Authors:  Mohamed Samir A Zaki; Refaat A Eid
Journal:  Saudi J Gastroenterol       Date:  2009-04       Impact factor: 2.485

9.  Differences in hepatic drug accumulation and enzyme induction after chronic amiodarone feeding of two rat strains: role of the hydroxylator phenotype?

Authors:  M Pirovino; U Honegger; O Müller; T Zysset; A Küpfer; M Tinel; D Pessayre
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

Review 10.  Pathogenesis and management issues for non-alcoholic fatty liver disease.

Authors:  Marko Duvnjak; Ivan Lerotić; Neven Barsić; Vedran Tomasić; Lucija Virović Jukić; Vedran Velagić
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.